Project Grant R21ES036166
Award Date
6/20/25
Completion Date
5/31/27
Dollars Obligated
$223K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $379,504 to the University System of New Hampshire, through its Keene State College division, to conduct research on understanding the mechanisms of arsenic toxicity in response to transgenerational chronic exposure. The key goals of the project are to: 1) detect tissue-specific uptake of arsenic using laser-ablation-ICP-MS techniques, 2)...
This Project Grant award of $260,000.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research to explore the basic molecular mechanism underlying skin blistering caused by exposure to chemical weapons. The University of Chicago, the awardee, will employ an integrative approach to investigate how skin vesicants, such as phenylarsine oxide and nitrogen...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $317,239 to the University of Texas Medical Branch at Galveston (UTMB) to investigate conserved inflammatory mechanisms of vesicant-induced skin injury. The research aims to map the distribution of transcriptional pathways and biomediators associated with localized damage from exposure to sulfur mustard and lewisite vesicants using...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, provides $646,476 to the University of California, Los Angeles (UCLA) to investigate how exposure to the environmental toxicant inorganic arsenic triggers epigenetic changes that can resist reprogramming during germ cell development. The overarching goal is to understand the metabolic mechanisms by which arsenic causes varied epigenetic...
This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), will support research to investigate the association between arsenic exposure and cancer incidence among residents with private wells in New Mexico's border counties. The research team from New Mexico State University will use urine biomarkers to detect arsenic contamination and identify DNA damage, oxidative stress, and...
This Cooperative Agreement award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) aims to develop novel medical countermeasures to mitigate gastrointestinal acute radiation syndrome (GI-ARS). The $515,326 award to Duke University will support research to define the mechanisms by which the protein clusterin promotes regeneration of the irradiated intestinal epithelium, and to investigate the role of the cGAS-STING pathway in regulating...
This Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) will provide $482,242 to The Medical College of Wisconsin, Inc. to conduct research on the mechanisms of mustard gas toxicity in the retina using a minipig model. The project aims to characterize the in vivo clinical, structural, and functional changes in the retina of a minipig model exposed to mustard gas, and identify molecular targets involved in retinal degenerative...
This Cooperative Agreement award from the National Institutes of Health's (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $552,787 to Old Dominion University to develop YK-4-250, a novel radiation mitigator targeted to the AT1 receptor, for the treatment of gastrointestinal acute radiation syndrome (GI-ARS). The research aims to investigate the mechanisms regulating the renin-angiotensin system and reactive oxygen species signaling to mitigate GI-ARS, with a focus on assessing...
This Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $590,302 to support research on developing next-generation platinum-based countermeasures and combination treatments to efficiently rescue toxic cyanide exposure. The primary objectives are to improve platinum-based agents as hydrogen cyanide scavengers, evaluate combinations with the metabolite glyoxylate, and assess the...
This Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) provides $226,464 to the University of Wisconsin-Milwaukee to develop a novel medical countermeasure for chlorine exposure. The research aims to demonstrate the therapeutic efficacy of GABA(A) receptor modulators in reducing acute lung injury caused by inhaled chlorine. Key objectives include determining the effects of nebulized and intramuscularly administered MIDD0301 in...